IL144228A0 - Use of apoptosis inducing agents in the treatment of (auto) immune diseases - Google Patents
Use of apoptosis inducing agents in the treatment of (auto) immune diseasesInfo
- Publication number
- IL144228A0 IL144228A0 IL14422800A IL14422800A IL144228A0 IL 144228 A0 IL144228 A0 IL 144228A0 IL 14422800 A IL14422800 A IL 14422800A IL 14422800 A IL14422800 A IL 14422800A IL 144228 A0 IL144228 A0 IL 144228A0
- Authority
- IL
- Israel
- Prior art keywords
- auto
- immune diseases
- treatment
- inducing agents
- apoptosis inducing
- Prior art date
Links
- 208000026278 immune system disease Diseases 0.000 title abstract 3
- 230000006907 apoptotic process Effects 0.000 title 1
- 230000001939 inductive effect Effects 0.000 title 1
- 102000010565 Apoptosis Regulatory Proteins Human genes 0.000 abstract 1
- 108010063104 Apoptosis Regulatory Proteins Proteins 0.000 abstract 1
- 230000001640 apoptogenic effect Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000001476 gene delivery Methods 0.000 abstract 1
- 230000006882 induction of apoptosis Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 210000002437 synoviocyte Anatomy 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99200056 | 1999-01-11 | ||
| PCT/NL2000/000013 WO2000041497A2 (en) | 1999-01-11 | 2000-01-10 | Use of apoptosis inducing agents in the treatment of (auto)immune diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL144228A0 true IL144228A0 (en) | 2002-05-23 |
Family
ID=8239795
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14422800A IL144228A0 (en) | 1999-01-11 | 2000-01-10 | Use of apoptosis inducing agents in the treatment of (auto) immune diseases |
| IL144228A IL144228A (en) | 1999-01-11 | 2001-07-10 | Use of apoptosis inducing agents in the preparation of a medicament for the treatment of (auto) immune diseases |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL144228A IL144228A (en) | 1999-01-11 | 2001-07-10 | Use of apoptosis inducing agents in the preparation of a medicament for the treatment of (auto) immune diseases |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20050271624A1 (no) |
| EP (1) | EP1143994B1 (no) |
| JP (1) | JP2003500336A (no) |
| AT (1) | ATE244014T1 (no) |
| AU (1) | AU3083500A (no) |
| CA (1) | CA2359392A1 (no) |
| DE (1) | DE60003632T2 (no) |
| DK (1) | DK1143994T3 (no) |
| EA (1) | EA200100770A1 (no) |
| ES (1) | ES2202039T3 (no) |
| HU (1) | HUP0200552A2 (no) |
| IL (2) | IL144228A0 (no) |
| MX (1) | MXPA01006998A (no) |
| NO (1) | NO20013397L (no) |
| PT (1) | PT1143994E (no) |
| TR (1) | TR200102713T2 (no) |
| WO (1) | WO2000041497A2 (no) |
| ZA (1) | ZA200105632B (no) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1377667E (pt) * | 2001-03-30 | 2009-03-13 | Leadd Bv | Proteínas de fusão para o tratamento específico de cancro e doenças auto-imunitárias |
| JP4584573B2 (ja) * | 2001-05-25 | 2010-11-24 | ナイモックス コーポレーション | 細胞の除去または破壊を必要とする腫瘍および他の状態の処置に有効なペプチド |
| EP1417227B1 (en) * | 2001-07-19 | 2007-01-10 | Nymox Corporation | Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| US7317077B2 (en) * | 2001-11-16 | 2008-01-08 | Nymox Pharmaceutical Corporation | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5670488A (en) * | 1992-12-03 | 1997-09-23 | Genzyme Corporation | Adenovirus vector for gene therapy |
| US5981502A (en) * | 1990-09-12 | 1999-11-09 | Leadd B.V. | Methods and compositions for inducing apoptosis in tumor cells |
| EP0878546A1 (en) * | 1997-04-15 | 1998-11-18 | Leadd B.V. | A gene delivery vehicle expressing the apoptosis-inducing proteins VP2 and/or apoptin |
| US5792751A (en) * | 1992-04-13 | 1998-08-11 | Baylor College Of Medicine | Tranformation of cells associated with fluid spaces |
| DK0830604T3 (da) * | 1995-06-07 | 2003-09-29 | Leadd Bv | Anvendelser af apoptin |
| WO1997029201A2 (de) * | 1996-02-07 | 1997-08-14 | Max-Delbrück-Centrum für Molekulare Medizin | Retroviraler vektor für den gentransfer eines il6-antagonisten in humane hämatopoetische stammzellen |
| CA2281567A1 (en) * | 1997-02-28 | 1998-09-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Self-regulated apoptosis of inflammatory cells by gene therapy |
| ZA982371B (en) * | 1997-03-21 | 1998-09-28 | Sankyo Co | Humanized anti-human fas antibody |
| JPH10324699A (ja) * | 1997-03-21 | 1998-12-08 | Sankyo Co Ltd | 抗ヒトＦａｓヒト化抗体 |
-
2000
- 2000-01-10 JP JP2000593120A patent/JP2003500336A/ja active Pending
- 2000-01-10 DE DE60003632T patent/DE60003632T2/de not_active Expired - Fee Related
- 2000-01-10 AU AU30835/00A patent/AU3083500A/en not_active Abandoned
- 2000-01-10 HU HU0200552A patent/HUP0200552A2/hu unknown
- 2000-01-10 CA CA002359392A patent/CA2359392A1/en not_active Abandoned
- 2000-01-10 PT PT00900970T patent/PT1143994E/pt unknown
- 2000-01-10 IL IL14422800A patent/IL144228A0/xx unknown
- 2000-01-10 EA EA200100770A patent/EA200100770A1/ru unknown
- 2000-01-10 MX MXPA01006998A patent/MXPA01006998A/es unknown
- 2000-01-10 DK DK00900970T patent/DK1143994T3/da active
- 2000-01-10 AT AT00900970T patent/ATE244014T1/de not_active IP Right Cessation
- 2000-01-10 TR TR2001/02713T patent/TR200102713T2/xx unknown
- 2000-01-10 WO PCT/NL2000/000013 patent/WO2000041497A2/en active IP Right Grant
- 2000-01-10 ES ES00900970T patent/ES2202039T3/es not_active Expired - Lifetime
- 2000-01-10 EP EP20000900970 patent/EP1143994B1/en not_active Expired - Lifetime
-
2001
- 2001-07-09 NO NO20013397A patent/NO20013397L/no not_active Application Discontinuation
- 2001-07-09 ZA ZA200105632A patent/ZA200105632B/en unknown
- 2001-07-10 IL IL144228A patent/IL144228A/en not_active IP Right Cessation
-
2005
- 2005-02-25 US US11/067,001 patent/US20050271624A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EA200100770A1 (ru) | 2002-02-28 |
| EP1143994B1 (en) | 2003-07-02 |
| CA2359392A1 (en) | 2000-07-20 |
| NO20013397D0 (no) | 2001-07-09 |
| MXPA01006998A (es) | 2002-05-06 |
| DE60003632T2 (de) | 2004-04-15 |
| HUP0200552A2 (en) | 2002-06-29 |
| AU3083500A (en) | 2000-08-01 |
| WO2000041497A2 (en) | 2000-07-20 |
| PT1143994E (pt) | 2003-11-28 |
| NO20013397L (no) | 2001-09-11 |
| ZA200105632B (en) | 2002-10-09 |
| TR200102713T2 (tr) | 2002-05-21 |
| ES2202039T3 (es) | 2004-04-01 |
| JP2003500336A (ja) | 2003-01-07 |
| WO2000041497A3 (en) | 2000-09-28 |
| EP1143994A2 (en) | 2001-10-17 |
| US20050271624A1 (en) | 2005-12-08 |
| ATE244014T1 (de) | 2003-07-15 |
| DK1143994T3 (da) | 2003-10-20 |
| DE60003632D1 (de) | 2003-08-07 |
| IL144228A (en) | 2009-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TNSN08064A1 (en) | Albumin fusion proteins | |
| PT1157042E (pt) | Produção de anticorpos tetravalentes | |
| MXPA02012743A (es) | Moleculas tipo il-17 y usos de las mismas. | |
| MXPA03002413A (es) | Moleculas tipo b7 y uso de las mismas. | |
| WO2003048327A3 (en) | Anti-cd45rb antibodies for use in treating autoimmune disease and transplant rejection | |
| MX2009002816A (es) | Proteinas de fusion de albumina. | |
| EP1005540A4 (en) | IKK-BETA PROTEINS, NUCLEIC ACIDS AND METHODS | |
| EP0851870A4 (en) | NUCLEIC ACID MOLECULES, PROTEINS AND PEPTIDES RELATED TO COLONIC AND COLONAL CANCER CELLS | |
| AU8881201A (en) | Tnf receptor-like molecules and uses thereof | |
| WO2003033658A3 (en) | Neutrokine-alpha and neutrokine-alpha splice variant | |
| WO2001098491A3 (en) | Osteolevin gene polymorphisms | |
| WO1999028461A3 (en) | Methods and means for inducing apoptosis by interfering with bip-like proteins | |
| IL144228A0 (en) | Use of apoptosis inducing agents in the treatment of (auto) immune diseases | |
| IL154298A0 (en) | Papap proteins, their preparation and use | |
| MXPA03000979A (es) | Moleculas tipo receptor de complemento c3b/c4b y usos de las mismas. | |
| PL374550A1 (en) | Il-17 like molecules and uses thereof | |
| EP1161262A4 (en) | COLLIGIN / HsP47 WITH SURFACE LOCATION IN CARCINOMA CELLS | |
| WO2002046458A3 (en) | Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof | |
| WO2004020591A3 (en) | Methods of use for novel human polypeptides encoded by polynucleotides | |
| EP1475441A3 (fr) | Acides nucléiques et polypeptides spécifiques des souches pathogènes du genre Neisseria | |
| WO2002072632A3 (en) | Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. | |
| WO2002079222A3 (en) | Fusion proteins for specific treatment of cancer and auto-immune diseases | |
| WO2001061010A3 (en) | GTPASE activating proteins | |
| WO2005035564A3 (en) | Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders | |
| WO2004039952A3 (en) | Methods of use for novel human polypeptides encoded by polynucleotides |